These results occur regardless of the nodal disease burden, yet our data show a highly significant difference in DSS between the N1 and N2 disease subgroups.
← all excerpts
Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients.
1
—
—